HMS
PCRX icon

Hanseatic Management Services’s Pacira BioSciences PCRX Stock Holding History

Hanseatic Management Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,987
Closed -$610K – 145
2022
Q1 		$610K Buy
+7,987
New +$532K 1.05% 29
2017
Q3 		– Sell
-15
Closed -$1K – 445
2017
Q2 		$1K Hold
15
– – ﹤0.01% 385
2017
Q1 		$1K Buy
+15
New +$648 ﹤0.01% 365

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Hanseatic Management Services's PCRX Position: Q2 2022 in Review

Hanseatic Management Services sold out of Pacira BioSciences (PCRX) in Q2 2022, closing a stake of 7,987 shares — an estimated $610K sold.

Hanseatic Management Services first reported a position in PCRX in Q1 2017 and held it in 3 quarters. The position peaked at $610K in Q1 2022. 284 funds tracked by Wall St. Rank hold PCRX as of Q2 2022.

  • Hanseatic Management Services reported no remaining Pacira BioSciences position as of Q2 2022 after selling out during the quarter.
  • Hanseatic Management Services sold 7,987 Pacira BioSciences shares in Q2 2022, an estimated $610K.
  • Hanseatic Management Services first reported a position in Pacira BioSciences in Q1 2017 and held it in 3 quarters.
  • Hanseatic Management Services's Pacira BioSciences position peaked at $610K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2022.

Based on Hanseatic Management Services's 13F filing for Q2 2022, filed 5 Aug 2022.